Regina Rabinovich

Biography

Regina Rabinovich is the ExxonMobil Malaria Scholar in Residence at Harvard University, and Director of the Malaria Elimination Initiative at ISGLOBAL at the University of Barcelona. She serves as the Chair of the Malaria Eradication Scientific Alliance, hosted at ISGLOBAL, and led the steering committee for the MalERA Refresh. She has over 25 years of experience in global health across research, public health, and philanthropic sectors, with focus on strategy, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations. Prior to joining Harvard, Dr. Rabinovich served as Director of the Infectious Diseases division at the Bill & Melinda Gates Foundation, overseeing the development and implementation of strategies for the prevention, treatment, and control of infectious diseases of particular relevance to malaria, pneumonia, diarrhea, and neglected infectious diseases. Dr. Rabinovich was Chief of the Clinical and Regulatory Affairs Branch at the US National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines through a network of US clinical research units. She participated in the Children's Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world. In 1999, Dr. Rabinovich became the founding director of the PATH Malaria Vaccine Initiative, a project funded by the Bill & Melinda Gates Foundation to advance efforts to develop promising malaria vaccine candidates. She is past president of the American Society of Tropical Medicine and Hygiene and serves on the boards of the Catholic Medical Mission Board (CMMB) and the Sabin Vaccine Institute. Dr. Rabinovich holds a medical degree from Southern Illinois University and a master's degree in Public Health degree from the University of North Carolina.

Education and Training

• B.A.,
  University of Iowa
• M.D.,
  S. Illinois University
• M.P.H.,
  University of North Carolina

Publications

• Ivermectin: repurposing an old drug to complement malaria vector control.

  Rabinovich NR. Lancet Infect Dis 2018 06

• Alan Magill, ASTMH Immediate Past President, 1953-2015.

  Rabinovich NR. Am J Trop Med Hyg 2015